Compare $CLRB vs $CNSY | Chartloom

Compare

$CLRB vs $CNSY

Cellectar Biosciences Inc · Plus Therapeutics Inc

CLRB

Cellectar Biosciences Inc

CNSY

Plus Therapeutics Inc

Compare $CLRB vs $CNSY

Comparing Cellectar Biosciences Inc and Plus Therapeutics Inc

CLRBCellectar Biosciences Inc

CNSYPlus Therapeutics Inc

CLRBCellectar Biosciences Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-58.2%

52W performance

-69.7%

FCF yield

-168.2%

CNSYPlus Therapeutics Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.12x

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-45.2%

FCF yield

-267.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLRB

CNSY

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

CNSY

Plus Therapeutics Inc

Market Cap

CLRB$12M

CNSY$13M

Enterprise Value

CLRB$-22M

CNSY$11M

Price

CLRB$1.45

CNSY$1.93

P/E Ratio

CLRBN/A

CNSYN/A

P/S Ratio

CLRB186.94x

CNSY3.16x

EV/Sales

CLRB-190.77x

CNSY2.60x

EV/EBITDA

CLRB0.00x

CNSY0.00x

P/B Ratio

CLRB0.56x

CNSY2.22x

P/FCF Ratio

CLRBN/A

CNSYN/A

EV/FCF

CLRB1.15x

CNSY-0.31x

PEG Ratio

CLRBN/A

CNSYN/A

Forward P/E (NTM)

CLRBN/A

CNSYN/A

Forward P/S (NTM)

CLRBN/A

CNSY1.12x

Revenue (TTM)

CLRB$0

CNSY$4M

Revenue Growth (YoY)

CLRBN/A

CNSYN/A

Forward Rev Growth

CLRB585.7%

CNSY216.6%

Gross Margin (TTM)

CLRB0.0%

CNSY0.0%

Operating Margin (TTM)

CLRB0.0%

CNSY0.0%

EBITDA Margin (TTM)

CLRB0.0%

CNSY-612.0%

Net Margin (TTM)

CLRB0.0%

CNSY-620.7%

FCF Margin (TTM)

CLRBN/A

CNSY-845.3%

Net Income (TTM)

CLRB$-22M

CNSY$-26M

FCF (TTM)

CLRB$-19M

CNSY$-36M

EPS (TTM)

CLRB-$1.83

CNSY-$3.78

ROE (TTM)

CLRB-16571.0%

CNSY-39417.0%

ROA (TTM)

CLRB-11542.0%

CNSY-15136.0%

ROIC (TTM)

CLRB-16571.0%

CNSY-37414.0%

Cash

CLRB$34M

CNSY$2M

Debt

CLRB$0

CNSY$0

Net Cash/Debt

CLRB$34M

CNSY$2M

Current Ratio (TTM)

CLRB6.66x

CNSY1.37x

Quick Ratio (TTM)

CLRB6.49x

CNSY1.26x

Debt/Equity (TTM)

CLRB0.00x

CNSY0.19x

Debt/Assets (TTM)

CLRB0.0%

CNSY0.0%

Interest Coverage (TTM)

CLRBN/A

CNSYN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

CNSY0.00x

Beta

CLRB0.58

CNSY2.21

52W Performance

CLRB-69.7%

CNSY-45.2%

YTD Performance

CLRB-58.2%

CNSY-45.2%

% from 52W High

CLRB-71.4%

CNSY-53.6%

% from 52W Low

CLRB8.2%

CNSY30.0%

Asset Turnover (TTM)

CLRB0.01x

CNSY0.24x

FCF Yield (TTM)

CLRB-168.2%

CNSY-267.6%

Earnings Yield (TTM)

CLRB-192.7%

CNSY-196.5%

Dividend Yield (TTM)

CLRBN/A

CNSYN/A

Rule of 40

CLRB0.0

CNSY-845.3

EV/GP/RG

CLRBN/A

CNSYN/A

Ticker research

View CLRB research View CNSY research

Metric	CLRB Cellectar Biosciences Inc	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$11M
Price	$1.45	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	3.16x
EV/Sales	-190.77x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-22M	$-26M
FCF (TTM)	$-19M	$-36M
EPS (TTM)	-$1.83	-$3.78
ROE (TTM)	-16571.0%	-39417.0%
ROA (TTM)	-11542.0%	-15136.0%
ROIC (TTM)	-16571.0%	-37414.0%
Financial Health
Cash	$34M	$2M
Debt	$0	$0
Net Cash/Debt	$34M	$2M
Current Ratio (TTM)	6.66x	1.37x
Quick Ratio (TTM)	6.49x	1.26x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	2.21
52W Performance	-69.7%	-45.2%
YTD Performance	-58.2%	-45.2%
% from 52W High	-71.4%	-53.6%
% from 52W Low	8.2%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.24x
FCF Yield (TTM)	-168.2%	-267.6%
Earnings Yield (TTM)	-192.7%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View CNSY research

Valuation

P/S Ratio

CNSY

3.16x

CLRB

186.94x

EV/FCF

CNSY

-0.31x

CLRB

1.15x

Growth & revenue

Forward Revenue Growth

CLRB

585.7%

CNSY

216.6%

Profitability & performance

Gross Margin

CLRB

0.0%

CNSY

0.0%

ROE

CLRB

-16571.0%

CNSY

-39417.0%

FCF Yield %

CLRB

-168.2%

CNSY

-267.6%

52-Week Performance

CNSY

-45.2%

CLRB

-69.7%

Detailed metrics comparison

CLRB

Cellectar Biosciences Inc

CNSY

Plus Therapeutics Inc

Market Cap

CLRB$12M

CNSY$13M

Enterprise Value

CLRB$-22M

CNSY$11M

Price

CLRB$1.45

CNSY$1.93

P/E Ratio

CLRBN/A

CNSYN/A

P/S Ratio

CLRB186.94x

CNSY3.16x

EV/Sales

CLRB-190.77x

CNSY2.60x

EV/EBITDA

CLRB0.00x

CNSY0.00x

P/B Ratio

CLRB0.56x

CNSY2.22x

P/FCF Ratio

CLRBN/A

CNSYN/A

EV/FCF

CLRB1.15x

CNSY-0.31x

PEG Ratio

CLRBN/A

CNSYN/A

Forward P/E (NTM)

CLRBN/A

CNSYN/A

Forward P/S (NTM)

CLRBN/A

CNSY1.12x

Revenue (TTM)

CLRB$0

CNSY$4M

Revenue Growth (YoY)

CLRBN/A

CNSYN/A

Forward Rev Growth

CLRB585.7%

CNSY216.6%

Gross Margin (TTM)

CLRB0.0%

CNSY0.0%

Operating Margin (TTM)

CLRB0.0%

CNSY0.0%

EBITDA Margin (TTM)

CLRB0.0%

CNSY-612.0%

Net Margin (TTM)

CLRB0.0%

CNSY-620.7%

FCF Margin (TTM)

CLRBN/A

CNSY-845.3%

Net Income (TTM)

CLRB$-22M

CNSY$-26M

FCF (TTM)

CLRB$-19M

CNSY$-36M

EPS (TTM)

CLRB-$1.83

CNSY-$3.78

ROE (TTM)

CLRB-16571.0%

CNSY-39417.0%

ROA (TTM)

CLRB-11542.0%

CNSY-15136.0%

ROIC (TTM)

CLRB-16571.0%

CNSY-37414.0%

Cash

CLRB$34M

CNSY$2M

Debt

CLRB$0

CNSY$0

Net Cash/Debt

CLRB$34M

CNSY$2M

Current Ratio (TTM)

CLRB6.66x

CNSY1.37x

Quick Ratio (TTM)

CLRB6.49x

CNSY1.26x

Debt/Equity (TTM)

CLRB0.00x

CNSY0.19x

Debt/Assets (TTM)

CLRB0.0%

CNSY0.0%

Interest Coverage (TTM)

CLRBN/A

CNSYN/A

Net Debt/EBITDA (TTM)

CLRB0.00x

CNSY0.00x

Beta

CLRB0.58

CNSY2.21

52W Performance

CLRB-69.7%

CNSY-45.2%

YTD Performance

CLRB-58.2%

CNSY-45.2%

% from 52W High

CLRB-71.4%

CNSY-53.6%

% from 52W Low

CLRB8.2%

CNSY30.0%

Asset Turnover (TTM)

CLRB0.01x

CNSY0.24x

FCF Yield (TTM)

CLRB-168.2%

CNSY-267.6%

Earnings Yield (TTM)

CLRB-192.7%

CNSY-196.5%

Dividend Yield (TTM)

CLRBN/A

CNSYN/A

Rule of 40

CLRB0.0

CNSY-845.3

EV/GP/RG

CLRBN/A

CNSYN/A

Ticker research

View CLRB research View CNSY research

Metric	CLRB Cellectar Biosciences Inc	CNSY Plus Therapeutics Inc
Market & Valuation
Market Cap	$12M	$13M
Enterprise Value	$-22M	$11M
Price	$1.45	$1.93
P/E Ratio	N/A	N/A
P/S Ratio	186.94x	3.16x
EV/Sales	-190.77x	2.60x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.56x	2.22x
P/FCF Ratio	N/A	N/A
EV/FCF	1.15x	-0.31x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1.12x
Revenue & Growth
Revenue (TTM)	$0	$4M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	585.7%	216.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-612.0%
Net Margin (TTM)	0.0%	-620.7%
FCF Margin (TTM)	N/A	-845.3%
Net Income (TTM)	$-22M	$-26M
FCF (TTM)	$-19M	$-36M
EPS (TTM)	-$1.83	-$3.78
ROE (TTM)	-16571.0%	-39417.0%
ROA (TTM)	-11542.0%	-15136.0%
ROIC (TTM)	-16571.0%	-37414.0%
Financial Health
Cash	$34M	$2M
Debt	$0	$0
Net Cash/Debt	$34M	$2M
Current Ratio (TTM)	6.66x	1.37x
Quick Ratio (TTM)	6.49x	1.26x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	2.21
52W Performance	-69.7%	-45.2%
YTD Performance	-58.2%	-45.2%
% from 52W High	-71.4%	-53.6%
% from 52W Low	8.2%	30.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.24x
FCF Yield (TTM)	-168.2%	-267.6%
Earnings Yield (TTM)	-192.7%	-196.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-845.3
EV/GP/RG	N/A	N/A
Ticker research	View CLRB research	View CNSY research